Identification of MAN1B1 as a Novel Marker for Bladder Cancer and Its Relationship with Immune Cell Infiltration

Table 3

Univariate and multivariate analysis of DSS in BLCA patients.

Characteristics	Total (N)	Univariate analysis		Multivariate analysis
		Hazard ratio (95% CI)	value	Hazard ratio (95% CI)	value
T stage	366
T1 & T2	124	Reference
T3	184	2.015 (1.262–3.216)	0.003	2.058 (0.873–4.853)	0.099
T4	58	3.243 (1.850–5.687)	<0.001	2.385 (0.851–6.682)	0.098
N stage	357
N0	233	Reference
N1	45	2.775 (1.675–4.599)	<0.001	2.259 (1.031–4.950)	0.042
N2 & N3	79	3.573 (2.341–5.452)	<0.001	2.896 (1.396–6.004)	0.004
M stage	208
M0	197	Reference
M1	11	4.205 (1.889–9.359)	<0.001	1.051 (0.337–3.282)	0.931
MAN1B1	399
Low	204	Reference
High	195	1.605 (1.126–2.286)	0.009	1.678 (0.915–3.076)	0.094
Age	399
<=70	226	Reference
>70	173	1.026 (0.718–1.466)	0.888
Gender	399
Female	103	Reference
Male	296	0.849 (0.576–1.251)	0.408